Cincinnati venture capital firm makes big hit on company sale

Story excerpt provided by Cincinnati Business Courier.

Written by Steve Watkins.

One of Cincinnati’s biggest venture capital firms, River Cities Capital Funds, reaped a big gain from the sale of one of its biggest holdings, but it wasn’t as much as River Cities might have hoped.

River Cities, which has raised more than $600 million for four funds to invest in growing companies, hauled in a profit from the sale of an Atlanta-based colonoscopy imaging product developer EndoChoice Holdings Inc. for $210 million to Boston Scientific (NYSE: BSX). That’s $8 a share.

Click here to read the complete article.

Originally published February 2, 2017.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: